pSivida Corp. Company Profile (NASDAQ:PSDV)

About pSivida Corp. (PSDV)

pSivida Corp. logopSivida Corp. develops drug delivery products primarily for the treatment of chronic eye diseases. The Company operates through the biotechnology sector segment. The Company has developed three products for treatment of back-of-the-eye diseases, which include Medidur for posterior segment uveitis, its lead product candidate that is in pivotal Phase III clinical trials; ILUVIEN for diabetic macular edema (DME), its lead licensed product that is sold in the United States and European Union (EU) countries, and Retisert. Medidur is designed to treat chronic non-infectious uveitis affecting the posterior segment of the eye (posterior segment uveitis). ILUVIEN is an injectable micro-insert that provides treatment of DME from a single injection. Retisert is an implant that provides treatment of posterior segment uveitis. Its product development program is focused on utilizing its two technology platforms, Durasert and Tethadur, to deliver drugs and biologics to treat chronic diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PSDV
  • CUSIP: N/A
Key Metrics:
  • Previous Close: $1.74
  • 50 Day Moving Average: $1.717
  • 200 Day Moving Average: $1.845
  • 52-Week Range: $1.50 - $4.25
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.89
  • P/E Growth: 0.000
  • Market Cap: $59.30M
  • Outstanding Shares: 34,176,000
  • Beta: 1.74
Profitability:
  • Net Margins: -271.33%
  • Return on Equity: -97.39%
  • Return on Assets: -66.37%
Debt:
  • Current Ratio: 3.77%
  • Quick Ratio: 3.77%

Analyst Ratings

Consensus Ratings for pSivida Corp. (NASDAQ:PSDV) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $7.00 (303.46% upside)

Analysts' Ratings History for pSivida Corp. (NASDAQ:PSDV)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
12/6/2016FBR & CoReiterated RatingOutperform$7.00N/AView Rating Details
12/29/2015Ladenburg Thalmann Financial ServicesReiterated RatingBuyN/AView Rating Details
12/17/2015Northland SecuritiesReiterated RatingBuyN/AView Rating Details
7/7/2015MLV & Co.Reiterated RatingBuy$6.50N/AView Rating Details
(Data available from 4/27/2015 forward)

Earnings

Earnings History for pSivida Corp. (NASDAQ:PSDV)
Earnings by Quarter for pSivida Corp. (NASDAQ:PSDV)
Earnings History by Quarter for pSivida Corp. (NASDAQ:PSDV)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2017        
11/7/2016Q1($0.19)($0.21)$0.30 million$0.28 millionViewListenView Earnings Details
9/12/2016Q4($0.13)($0.19)$2.40 million$0.30 millionViewListenView Earnings Details
5/5/2016Q3($0.20)($0.15)$1.75 million$0.32 millionViewN/AView Earnings Details
11/5/2015Q116($0.15)($0.17)$0.50 million$0.47 millionViewN/AView Earnings Details
9/9/2015Q415($0.14)($0.17)$0.60 million$0.41 millionViewN/AView Earnings Details
5/8/2015Q315($0.13)($0.17)$0.33 millionViewN/AView Earnings Details
2/5/2015($0.13)($0.14)$0.52 millionViewN/AView Earnings Details
11/7/2014Q3 14($0.12)$0.67$25.30 millionViewN/AView Earnings Details
9/9/2014Q414($0.15)($0.15)$0.29 millionViewN/AView Earnings Details
5/13/2014Q314($0.15)($0.03)$0.55 million$2.00 millionViewN/AView Earnings Details
2/7/2014Q214($0.13)($0.13)$430.00 million$0.59 millionViewN/AView Earnings Details
11/12/2013Q1($0.14)ViewListenView Earnings Details
9/25/2013Q413($0.12)($0.17)$0.65 million$0.49 millionViewN/AView Earnings Details
2/6/2013Q2 2013($0.11)$0.63 million$0.59 millionViewListenView Earnings Details
11/8/2012Q113($0.10)($0.11)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for pSivida Corp. (NASDAQ:PSDV)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20171($0.19)($0.19)($0.19)
Q3 20171($0.17)($0.17)($0.17)
Q4 20171($0.15)($0.15)($0.15)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for pSivida Corp. (NASDAQ:PSDV)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for pSivida Corp. (NASDAQ:PSDV)
Insider Ownership Percentage: 4.49%
Institutional Ownership Percentage: 29.03%
Insider Trades by Quarter for pSivida Corp. (NASDAQ:PSDV)
Institutional Ownership by Quarter for pSivida Corp. (NASDAQ:PSDV)
Insider Trades by Quarter for pSivida Corp. (NASDAQ:PSDV)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/4/2016Leonard S. RossVPSell5,000$4.70$23,500.00View SEC Filing  
12/22/2015Leonard S. RossVPSell33,950$5.39$182,990.50View SEC Filing  
12/22/2015Paul AshtonCEOSell120,000$5.39$646,800.00View SEC Filing  
10/1/2014Paul AshtonCEOSell10,000$4.27$42,700.00View SEC Filing  
9/2/2014Paul AshtonCEOSell10,000$4.78$47,800.00View SEC Filing  
8/1/2014Paul AshtonCEOSell10,000$4.37$43,700.00View SEC Filing  
7/1/2014Paul AshtonCEOSell10,000$4.32$43,200.00View SEC Filing  
6/19/2014Paul AshtonCEOSell7,000$4.00$28,000.00View SEC Filing  
6/17/2014Lori FreedmanVPSell7,900$4.00$31,600.00View SEC Filing  
6/17/2014Paul AshtonCEOSell7,700$4.00$30,800.00View SEC Filing  
6/13/2014Lori FreedmanVPSell11,700$4.02$47,034.00View SEC Filing  
6/13/2014Paul AshtonCEOSell11,800$4.02$47,436.00View SEC Filing  
10/1/2012Paul HopperDirectorBuy10,000$1.68$16,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for pSivida Corp. (NASDAQ:PSDV)
Latest Headlines for pSivida Corp. (NASDAQ:PSDV)
Source:
DateHeadline
americanbankingnews.com logoSomewhat Negative Media Coverage Very Likely to Affect pSivida Corp. (PSDV) Stock Price
www.americanbankingnews.com - April 26 at 1:23 PM
americanbankingnews.com logoSomewhat Positive Press Coverage Very Likely to Affect pSivida Corp. (PSDV) Share Price
www.americanbankingnews.com - April 23 at 5:51 PM
americanbankingnews.com logopSivida Corp. (PSDV) Sees Large Decrease in Short Interest
www.americanbankingnews.com - April 19 at 10:20 PM
finance.yahoo.com logopSivida Corp. to Report Third Quarter Fiscal Year 2017 Financial Results on Thursday, May 4th
finance.yahoo.com - April 19 at 7:21 PM
finance.yahoo.com logoETFs with exposure to pSivida Corp. : April 11, 2017
finance.yahoo.com - April 11 at 7:10 PM
streetinsider.com logopSivida (PSDV) Says Abstract on Treatment of Posterior Segment Uveitis Accepted for Presentation at ARVO - StreetInsider.com
www.streetinsider.com - March 16 at 8:25 AM
streetinsider.com logopSivida (PSDV) Says Abstract on Treatment of Posterior Segment Uveitis Accepted for Presentation at ARVO
www.streetinsider.com - March 15 at 9:14 AM
finance.yahoo.com logoAbstract on pSivida's Treatment of Posterior Segment Uveitis Accepted for Presentation at the 2017 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
finance.yahoo.com - March 15 at 9:14 AM
biz.yahoo.com logoPSIVIDA CORP. Files SEC form 8-K, Other Events
biz.yahoo.com - March 6 at 6:42 PM
seekingalpha.com logopSivida (PSDV) Presents At 19th Annual BIO CEO & Investor Conference - Slideshow
seekingalpha.com - February 16 at 6:57 PM
seekingalpha.com logopSivida (PSDV) Presents At 19th Annual BIO CEO & Investor Conference - Slideshow
seekingalpha.com - February 16 at 6:57 PM
finance.yahoo.com logoPSIVIDA CORP. Financials
finance.yahoo.com - February 16 at 6:57 PM
finance.yahoo.com logoPSIVIDA CORP. Financials
finance.yahoo.com - February 16 at 6:57 PM
globenewswire.com logopSivida to Present at the 2017 BIO CEO & Investor Conference - GlobeNewswire (press release)
globenewswire.com - February 11 at 2:32 AM
finance.yahoo.com logopSivida to Present at the 2017 BIO CEO & Investor Conference
finance.yahoo.com - February 10 at 9:30 PM
biz.yahoo.com logoPSIVIDA CORP. Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - February 9 at 10:02 PM
biz.yahoo.com logoPSIVIDA CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
us.rd.yahoo.com - February 9 at 2:15 AM
globenewswire.com logopSivida Corp. Reports Fiscal 2017 Second Quarter and First Half Results - GlobeNewswire (press release)
www.globenewswire.com - February 8 at 9:12 PM
finance.yahoo.com logoEdited Transcript of PSDV earnings conference call or presentation 7-Feb-17 9:30pm GMT
finance.yahoo.com - February 8 at 9:12 PM
biz.yahoo.com logoPSIVIDA CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
biz.yahoo.com - February 8 at 9:12 PM
us.rd.yahoo.com logopSivida Corp. Reports Fiscal 2017 Second Quarter and First Half Results
us.rd.yahoo.com - February 7 at 9:59 PM
biz.yahoo.com logoQ2 2017 pSivida Corp Earnings Release - After Market Close
biz.yahoo.com - February 7 at 8:43 AM
feeds.benzinga.com logopSivida Corp. Announces Second Quarter Fiscal Year 2017 Financial Results Release Date and Conference Call Information
feeds.benzinga.com - January 25 at 8:49 AM

Social

Frequently Asked Questions for pSivida Corp. (NASDAQ:PSDV)

What is pSivida Corp.'s stock symbol?

pSivida Corp. trades on the NASDAQ under the ticker symbol "PSDV."

How were pSivida Corp.'s earnings last quarter?

pSivida Corp. (NASDAQ:PSDV) posted its earnings results on Monday, September, 12th. The company reported ($0.19) EPS for the quarter, missing the Zacks' consensus estimate of ($0.13) by $0.06. The company earned $0.30 million during the quarter, compared to analyst estimates of $2.40 million. pSivida Corp. had a negative net margin of 271.33% and a negative return on equity of 97.39%.

When will pSivida Corp. make its next earnings announcement?

pSivida Corp. is scheduled to release their next quarterly earnings announcement on Wednesday, May, 3rd 2017.

Where is pSivida Corp.'s stock going? Where will pSivida Corp.'s stock price be in 2017?

1 equities research analysts have issued 12-month target prices for pSivida Corp.'s shares. Their forecasts range from $7.00 to $7.00. On average, they anticipate pSivida Corp.'s share price to reach $7.00 in the next twelve months.

Are investors shorting pSivida Corp.?

pSivida Corp. saw a decline in short interest during the month of March. As of March 31st, there was short interest totalling 230,323 shares, a decline of 5.4% from the March 15th total of 243,480 shares. Based on an average trading volume of 300,575 shares, the days-to-cover ratio is presently 0.8 days.

How do I buy pSivida Corp. stock?

Shares of pSivida Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of pSivida Corp. stock cost?

One share of pSivida Corp. stock can currently be purchased for approximately $1.74.

pSivida Corp. (PSDV) Chart for Thursday, April, 27, 2017

This page was last updated on 4/27/2017 by MarketBeat.com Staff